Posted on

Pancreatin for Pancreatic Exocrine Insufficiency (PEI) in adults with pancreatic cancer

General Track – Cycle 2 | Drugs

HTA Council Recommendation (as of 08 April 2025)

The HTA Council positively recommends the government financing of Pancreatin for pancreatic exocrine insufficiency (PEI) in adults with pancreatic cancer (See below for more details)

Relevant Information

  • Dosage Strength: 150 mg
  • Dosage Form: capsule
  • Status: With Final HTA Council Recommendation
  • Topic Assignment: Internal Assessment
  • Policy Question: Should Pancreatin for pancreatic exocrine insufficiency (PEI) in adults with pancreatic cancer be funded by the government?
  • Secretary of Health Decision: Approved for inclusion in the Philippine National Formulary

Evidence and Relevant Documents

Assessments Page